Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Van Hemelrijck, Mieke"'
Autor:
Turner MC; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Radzikowska U; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.; Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland., Ferastraoaru DE; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA., Pascal M; Immunology Department, Centre de Diagnòstic Biomèdic, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Department of Medicine, Faculty of Medicine, Universitat de Barcelona, Barcelona, Spain., Wesseling P; Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, The Netherlands.; Laboratory for Childhood Cancer Pathology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., McCraw A; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK., Backes C; National Cancer Registry (Registre National du Cancer (RNC)), Luxembourg Institute of Health (LIH), Strassen, Luxembourg.; Public Health Expertise Unit, Department of Precision Health, Cancer Epidemiology and Prevention (EPI CAN), Luxembourg Institute of Health, Strassen, Luxembourg., Bax HJ; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK., Bergmann C; Department of Otorhinolaryngology, RKM740 Interdisciplinary Clinics, Düsseldorf, Germany., Bianchini R; Center of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.; The Interuniversity Messerli Research Institute Vienna, University of Veterinary Medecine Vienna, Medical University Vienna, University Vienna, Vienna, Austria., Cari L; Section of Pharmacology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., de Las Vecillas L; Department of Allergy, La Paz University Hospital - IdiPAZ, Madrid, Spain., Izquierdo E; Institute of Applied Molecular Medicine Instituto de Medicina Molecular Aplicada Nemesio Díez (IMMA), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Lind-Holm Mogensen F; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Sciences, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Michelucci A; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg., Nazarov PV; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, Strassen, Luxembourg., Niclou SP; Faculty of Sciences, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.; NORLUX Neuro-Oncology laboratory, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg., Nocentini G; Section of Pharmacology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Ollert M; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-Sur-Alzette, Luxembourg.; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Rohr-Udilova N; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Liver Cancer (HCC) Study Group Vienna, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria., Scafidi A; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.; Faculty of Sciences, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Toth R; Multiomics Data Science, Department of Cancer Research, Luxembourg Institute of Health, Strassen, Luxembourg., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Jappe U; Division of Clinical and Molecular Allergology, Priority Research Area Chronic Lung Diseases, Research Center Borstel, Leibniz Lung Center, German Center for Lung Research (DZL), Airway Research Center North (ARCN), Borstel, Germany.; Department of Pneumology, Interdisciplinary Allergy Outpatient Clinic, University of Luebeck, Luebeck, Germany., Escribese MM; Institute of Applied Molecular Medicine Instituto de Medicina Molecular Aplicada Nemesio Díez (IMMA), Department of Basic Medical Sciences, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain., Jensen-Jarolim E; Center of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.; The Interuniversity Messerli Research Institute Vienna, University of Veterinary Medecine Vienna, Medical University Vienna, University Vienna, Vienna, Austria., Karagiannis SN; St. John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, Guy's Hospital, London, UK.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, Innovation Hub, Guy's Cancer Centre, London, UK., Poli A; Neuro-Immunology Group, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.
Publikováno v:
Allergy [Allergy] 2024 Jun; Vol. 79 (6), pp. 1419-1439. Date of Electronic Publication: 2024 Jan 24.
Autor:
Santaolalla A; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK. aida.santaolalla@kcl.ac.uk.; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. aida.santaolalla@kcl.ac.uk., Sollie S; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK., Rislan A; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK., Josephs DH; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK.; Department of Medical Oncology, Guy's and St Thomas' NHS Trust, London, UK., Hammar N; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Walldius G; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Garmo H; Regional Cancer Center, Uppsala/Örebro, Uppsala University Hospital, Uppsala, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Karagiannis SN; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, Guy's Hospital, London, UK.; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, 3rd Floor, Bermondsey Wing, London, SE1 9RT, UK.; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
BMC immunology [BMC Immunol] 2021 Sep 06; Vol. 22 (1), pp. 61. Date of Electronic Publication: 2021 Sep 06.
Autor:
Monroy-Iglesias MJ; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Russell B; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Crawley D; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Allen NE; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK., Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Perez-Cornago A; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Beckmann K; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Cancer Research Institute, University of South Australia, Adelaide, Australia.
Publikováno v:
International journal of cancer [Int J Cancer] 2021 Feb 15; Vol. 148 (4), pp. 825-834. Date of Electronic Publication: 2020 Sep 11.
Autor:
Walldius G; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine., Malmström H; Unit of Epidemiology, Institute of Environmental Medicine., Jungner I; Unit of Epidemiology, Institute of Environmental Medicine., de Faire U; Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine., Lambe M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Regional Cancer Centre, Uppsala, Sweden., Van Hemelrijck M; Kings College London, Cancer Epidemiology Group, London, UK., Hammar N; Unit of Epidemiology, Institute of Environmental Medicine.; Medical Evidence & Observational Research, AstraZeneca, Mölndal, Sweden.
Publikováno v:
International journal of epidemiology [Int J Epidemiol] 2017 Aug 01; Vol. 46 (4), pp. 1103-1103i.
Autor:
Van Hemelrijck M; King's College London, School of Medicine, Division of Cancer Studies, Cancer Epidemiology Group, London, United Kingdom. mieke.vanhemelrijck@kcl.ac.uk, Jungner I, Walldius G, Garmo H, Binda E, Hayday A, Lambe M, Holmberg L, Hammar N
Publikováno v:
International journal of cancer [Int J Cancer] 2011 Sep 15; Vol. 129 (6), pp. 1485-92. Date of Electronic Publication: 2011 Jan 12.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Santaolalla, Aida, Garmo, Hans, Grigoriadis, Anita, Ghuman, Sundeep, Hammar, Niklas, Jungner, Ingmar, Walldius, Göran, Lambe, Mats, Holmberg, Lars, Van Hemelrijck, Mieke
Publikováno v:
BMC Molecular and Cell Biology
Santa Olalla, A, Van Hemelrijck, M, Holmberg, L H, Grigoriadis, A, Ghuman, S, Hammar, N, Lambe, M, Garmo, H G, Walldius, G & Jungner, I 2019, ' Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis ', BMC Molecular Biology, vol. 20, no. 1, 28 . https://doi.org/10.1186/s12860-019-0210-7
BMC Molecular and Cell Biology, Vol 20, Iss 1, Pp 1-15 (2019)
Santa Olalla, A, Van Hemelrijck, M, Holmberg, L H, Grigoriadis, A, Ghuman, S, Hammar, N, Lambe, M, Garmo, H G, Walldius, G & Jungner, I 2019, ' Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis ', BMC Molecular Biology, vol. 20, no. 1, 28 . https://doi.org/10.1186/s12860-019-0210-7
BMC Molecular and Cell Biology, Vol 20, Iss 1, Pp 1-15 (2019)
Background Metabolites are genetically and environmentally determined. Consequently, they can be used to characterize environmental exposures and reveal biochemical mechanisms that link exposure to disease. To explore disease susceptibility and impro
Autor:
Nakamura, Mano, Bax, Heather J., Scotto, Daniele, Souri, Elmira Amiri, Sollie, Sam, Harris, Robert J., Hammar, Niklas, Walldius, Goran, Winship, Anna, Ghosh, Sharmistha, Montes, Ana, Spicer, James F., Van Hemelrijck, Mieke, Josephs, Debra H., Lacy, Katie E., Tsoka, Sophia, Karagiannis, Sophia N.
Publikováno v:
Oncoimmunology
Nakamura, M, Bax, H J, Scotto, D, Amiri Souri, E, Sollie, S, Harris, R J, Hammar, N, Walldius, G, Winship, A, Ghosh, S, Montes, A, Spicer, J F, Van Hemelrijck, M, Josephs, D H, Lacy, K E, Tsoka, S & Karagiannis, S N 2019, ' Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma ', OncoImmunology, vol. 8, no. 6, e1593811 . https://doi.org/10.1080/2162402X.2019.1593811
OncoImmunology, Vol 8, Iss 6 (2019)
Nakamura, M, Bax, H J, Scotto, D, Amiri Souri, E, Sollie, S, Harris, R J, Hammar, N, Walldius, G, Winship, A, Ghosh, S, Montes, A, Spicer, J F, Van Hemelrijck, M, Josephs, D H, Lacy, K E, Tsoka, S & Karagiannis, S N 2019, ' Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma ', OncoImmunology, vol. 8, no. 6, e1593811 . https://doi.org/10.1080/2162402X.2019.1593811
OncoImmunology, Vol 8, Iss 6 (2019)
Immune and inflammatory cascades may play multiple roles in ovarian cancer. We aimed to identify relationships between expression of immune and inflammatory mediators and patient outcomes. We interrogated differential gene expression of 44 markers an